PETMED EXPRESS INC

For the period ended Mar 31, 2025. Filed Oct 14, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Oct 14, 2025

PETS$1.21-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of and

	March 31,2025	March 31,2024
ASSETS
Current assets:
Cash and cash equivalents	$54,720	$55,296
Accounts receivable, less allowance for credit losses of $91 and $273, respectively	2,317	3,283
Inventories, net	16,205	28,556
Prepaid expenses and other current assets	5,330	6,325
Prepaid income taxes	299	188
Total current assets	78,871	93,648
Noncurrent assets:
Property and equipment, net	28,859	26,657
Intangible and other assets, net	13,346	16,503
Goodwill	26,658	26,658
Operating lease right-of-use assets, net	966	1,432
Deferred tax assets, net	—	4,986
Total noncurrent assets	69,829	76,236
Total assets	$148,700	$169,884
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$23,564	$37,024
Sales tax payable	24,867	25,012
Accrued expenses and other current liabilities	11,711	7,060
Current operating lease liabilities	461	459
Deferred revenue	2,085	2,603
Income taxes payable	80	—
Total current liabilities	62,768	72,158
Deferred tax liabilities, net	263	—
Long-term operating lease liabilities	535	995
Total liabilities	$63,566	$73,153
Commitments and contingencies (Note 15)
Shareholders' equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized:
Convertible Preferred stock, $0.001 par value, with a liquidation preference of $4 per share, 250,000 shares authorized ; 2,500 and 2,500 convertible shares issued and outstanding, respectively	9	9
Series A Junior Participating Preferred Stock, $0.001 par value, 100,000 shares authorized; no shares issued or outstanding	—	—
Common stock, $.001 par value, 40,000,000 shares authorized; 20,656,822 and 21,148,692 shares issued and outstanding, respectively	21	21
Additional paid-in capital	18,560	25,146
Retained earnings	66,544	71,555
Total shareholders' equity	85,134	96,731
Total liabilities and shareholders' equity	$148,700	$169,884

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.